Skip to content
thispeptide

Thriving Again

Thriving Again presents men’s hormone, weight and wellness care with ongoing messaging. The public material does not establish a named eligible GLP-1 or peptide preparation, assigned clinician or complete prescription price.

Review by Molly Ward, goal-guide writer · Updated October 2026

    The short version

    Ask for the actual medical practice, clinician, pharmacy and proposed drug before committing. The current disclosures support a critical assessment of the service, but they do not justify comparing a specific prescription or assuming broad wellness claims are established.

    Disclosure: This Peptide is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.

    Thriving Again LLC markets men’s health through sexual health, weight management, testosterone care and hair restoration. A general GLP-1 prescription pathway is shown without identifying a particular molecule on the public homepage. The longevity section names BPC-157 and ipamorelin as examples for discussion. Those research-stage examples are not eligible treatments in these comparisons. No semaglutide, tirzepatide or other specific eligible molecule is inferred from the GLP-1 category.

    Treatment details to confirm

    The public program does not identify an eligible named peptide and formulation for comparison. Confirm the actual prescription, preparation and treating practice before choosing a program.

    Who prescribes

    A licensed clinician

    The homepage claims a nationwide network of licensed, board-certified providers but does not name an individual prescriber or a specific medical group. A numerical provider count is not a directory a patient can verify. The pharmacy and its location are also not identified. Request the treating practice, clinician and actual dispenser before deciding whether the proposed care arrangement is suitable.

    The website directs patients toward goal-specific online questionnaires. Their public initial pages ask about goals without establishing a full treatment protocol. A provider must approve prescription treatment. The homepage describes ongoing care and messaging with the clinical team, but a universal live consultation, routine visit interval and response guarantee are not established. Clarify how follow-up occurs and how clinical concerns reach the prescriber.

    Are labs required?

    Exact testing scope not established

    Metabolic and hormone testing are advertised, including an at-home hormone panel. A universal required weight-program panel, included testing amount and repeat schedule are not established publicly. Ask which tests apply to the actual proposed treatment.

    Ready to start with Thriving Again?

    Prices and plans are set on the seller's own site.

    What it claims, and what it cites

    The website uses large provider, satisfaction and member counts alongside individual treatment stories. These are marketing claims rather than a controlled study of the complete service. A patient’s testosterone or weight experience does not establish efficacy for a different preparation. The page also acknowledges that compounded products are not FDA-approved or evaluated for safety, effectiveness or quality.

    Other products and treatment claims

    BPC-157 and ipamorelin examples
    These research-stage compounds are not included as eligible clinical comparisons; discussion on a wellness page does not establish approval or adequate evidence.

    How it bills

    A hormone-and-peptide program banner starts at $149 monthly. It is not assigned to a named eligible medicine, route, dose or supplied quantity. The initial assessment is advertised as free, which does not establish free clinical treatment or laboratory work. The page does not establish a comparable medication price. The refund page says all sales are final and offers no refunds. Future recurring billing can be stopped by contacting support, but there is no clear universal notice cutoff. The page warns that the next cycle may already have processed. Obtain the complete payment and cancellation agreement before purchase.

    For and against

    • For: Prescription approval required
    • For: Ongoing care and messaging described
    • For: Refund policy available publicly
    • For: Compound approval limitation acknowledged
    • Against: No named eligible prescription established
    • Against: Actual medical practice and pharmacy unclear
    • Against: Headline lacks product and supply scope
    • Against: Final-sale policy with unclear notice cutoff

    Right for

    Someone prepared to obtain specific clinical identities and a complete written prescription proposal before deciding whether the service fits.

    Look elsewhere if

    A patient who needs a named medicine, verified clinical roster and complete public treatment price before starting.

    Thriving Again

    Frequently asked questions

    Does the GLP-1 label identify semaglutide?
    No. The public material reviewed does not assign a particular eligible molecule to that category.
    Is the $149 banner a verified peptide prescription rate?
    No. It covers a broad program without naming the actual medicine, route, dose and quantity.
    Does stopping future billing refund a paid order?
    The refund page says all sales are final and does not promise a refund when future billing is canceled.

    Sources

    • Current program categories and disclosures
    • Refund and future-billing policy
    • Public company privacy information

    See what Thriving Again prescribes today

    Thriving Again sets its own prices, plans and the states it serves. Check them before you start.

    Written by Molly Ward from Thriving Again’s own public pages, against the published methodology. No outcome is claimed first-hand and no score is given. A partnership never changes what this page says; see how the site is paid.